These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 9755379)

  • 1. Verapamil use in patients with cardiovascular disease: an overview of randomized trials.
    Pepine CJ; Faich G; Makuch R
    Clin Cardiol; 1998 Sep; 21(9):633-41. PubMed ID: 9755379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Verapamil-sustained release-based treatment strategy is equivalent to atenolol-based treatment strategy at reducing cardiovascular events in patients with prior myocardial infarction: an INternational VErapamil SR-Trandolapril (INVEST) substudy.
    Bangalore S; Messerli FH; Cohen JD; Bacher PH; Sleight P; Mancia G; Kowey P; Zhou Q; Champion A; Pepine CJ;
    Am Heart J; 2008 Aug; 156(2):241-7. PubMed ID: 18657652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term effects of diltiazem and verapamil on mortality and cardiac events in non-Q-wave acute myocardial infarction without pulmonary congestion: post hoc subset analysis of the multicenter diltiazem postinfarction trial and the second danish verapamil infarction trial studies.
    Gibson RS; Hansen JF; Messerli F; Schechtman KB; Boden WE
    Am J Cardiol; 2000 Aug; 86(3):275-9. PubMed ID: 10922432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Principal results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) trial.
    Black HR; Elliott WJ; Grandits G; Grambsch P; Lucente T; White WB; Neaton JD; Grimm RH; Hansson L; Lacourciere Y; Muller J; Sleight P; Weber MA; Williams G; Wittes J; Zanchetti A; Anders RJ;
    JAMA; 2003 Apr 23-30; 289(16):2073-82. PubMed ID: 12709465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rationale and design of the International Verapamil SR/Trandolapril Study (INVEST): an Internet-based randomized trial in coronary artery disease patients with hypertension.
    Pepine CJ; Handberg-Thurmond E; Marks RG; Conlon M; Cooper-DeHoff R; Volkers P; Zellig P
    J Am Coll Cardiol; 1998 Nov; 32(5):1228-37. PubMed ID: 9809930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A controlled trial of verapamil in patients after acute myocardial infarction: results of the calcium antagonist reinfarction Italian study (CRIS).
    Rengo F; Carbonin P; Pahor M; DeCaprio L; Bernabei R; Ferrara N; Carosella L; Acanfora D; Parlati S; Vitale D
    Am J Cardiol; 1996 Feb; 77(5):365-9. PubMed ID: 8602564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial.
    Pepine CJ; Handberg EM; Cooper-DeHoff RM; Marks RG; Kowey P; Messerli FH; Mancia G; Cangiano JL; Garcia-Barreto D; Keltai M; Erdine S; Bristol HA; Kolb HR; Bakris GL; Cohen JD; Parmley WW;
    JAMA; 2003 Dec; 290(21):2805-16. PubMed ID: 14657064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Favourable long term prognosis in stable angina pectoris: an extended follow up of the angina prognosis study in Stockholm (APSIS).
    Hjemdahl P; Eriksson SV; Held C; Forslund L; Näsman P; Rehnqvist N
    Heart; 2006 Feb; 92(2):177-82. PubMed ID: 15951393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prognostic significance of angina pectoris experienced during the first month following acute myocardial infarction.
    Jespersen CM
    Clin Cardiol; 1997 Jul; 20(7):623-6. PubMed ID: 9220178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prognostic significance of post-infarction angina pectoris and the effect of verapamil on the incidence of angina pectoris and prognosis. The Danish Study Group on Verapamil in Myocardial Infarction.
    Jespersen CM; Hansen JF; Mortensen LS
    Eur Heart J; 1994 Feb; 15(2):270-6. PubMed ID: 8005130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Calcium antagonists in cardiovascular disease. Clinical evidence from morbidity and mortality trials].
    Oparil S; Bakir SE
    Drugs; 2000; 59 Spec No 2():25-37. PubMed ID: 11002856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of metoprolol vs verapamil in patients with stable angina pectoris. The Angina Prognosis Study in Stockholm (APSIS).
    Rehnqvist N; Hjemdahl P; Billing E; Björkander I; Eriksson SV; Forslund L; Held C; Näsman P; Wallén NH
    Eur Heart J; 1996 Jan; 17(1):76-81. PubMed ID: 8682134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcium channel blockers in acute myocardial infarction and unstable angina: an overview.
    Held PH; Yusuf S; Furberg CD
    BMJ; 1989 Nov; 299(6709):1187-92. PubMed ID: 2513047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibrinolytic variables and cardiovascular prognosis in patients with stable angina pectoris treated with verapamil or metoprolol. Results from the Angina Prognosis study in Stockholm.
    Held C; Hjemdahl P; Rehnqvist N; Wallén NH; Björkander I; Eriksson SV; Forslund L; Wiman B
    Circulation; 1997 May; 95(10):2380-6. PubMed ID: 9170400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heart rate-lowering calcium antagonists in hypertensive post-myocardial infarction patients.
    Messerli FH; Hansen JF; Gibson RS; Schechtman KB; Boden WE
    J Hypertens; 2001 May; 19(5):977-82. PubMed ID: 11393682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of early treatment with anti-hypertensive drugs on short and long-term mortality in patients with an acute cardiovascular event.
    Perez MI; Musini VM; Wright JM
    Cochrane Database Syst Rev; 2009 Oct; (4):CD006743. PubMed ID: 19821384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic implications of results from exercise testing in patients with chronic stable angina pectoris treated with metoprolol or verapamil. A report from the Angina Prognosis Study In Stockholm (APSIS).
    Forslund L; Hjemdahl P; Held C; Björkander I; Eriksson SV; Brodin U; Rehnqvist N
    Eur Heart J; 2000 Jun; 21(11):901-10. PubMed ID: 10806014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current status of safety and efficacy of calcium channel blockers in cardiovascular diseases: a critical analysis based on 100 studies.
    Opie LH; Yusuf S; Kübler W
    Prog Cardiovasc Dis; 2000; 43(2):171-96. PubMed ID: 11014332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meta-analysis of trials comparing beta-blockers, calcium antagonists, and nitrates for stable angina.
    Heidenreich PA; McDonald KM; Hastie T; Fadel B; Hagan V; Lee BK; Hlatky MA
    JAMA; 1999 May; 281(20):1927-36. PubMed ID: 10349897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of oral propranolol and verapamil for combined systemic hypertension and angina pectoris. A placebo-controlled double-blind randomized crossover trial.
    Frishman WH; Klein NA; Klein P; Strom JA; Tawil R; Strair R; Wong B; Roth S; LeJemtel TH; Pollack S; Sonnenblick EH
    Am J Cardiol; 1982 Nov; 50(5):1164-72. PubMed ID: 6127946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.